Read more about the article Regeneron and Sanofi Announce Dupixent Outperformance over Xolair in Phase 4 EVEREST Trial Results for CRSwNP and Asthma
Regeneron and Sanofi Announce Dupixent Outperformance over Xolair in Phase 4 EVEREST Trial Results for CRSwNP and Asthma

Regeneron and Sanofi Announce Dupixent Outperformance over Xolair in Phase 4 EVEREST Trial Results for CRSwNP and Asthma

Dupixent surpassed Xolair in treating CRSwNP and asthma, improving symptoms and quality of life significantly.Quiver AI SummaryNew findings from the EVEREST Phase 4 trial presented at the 2025 EAACI Congress…

Continue ReadingRegeneron and Sanofi Announce Dupixent Outperformance over Xolair in Phase 4 EVEREST Trial Results for CRSwNP and Asthma
Read more about the article Intellia Therapeutics Reports Promising Three-Year Follow-Up Data for Lonvo-z in Hereditary Angioedema Patients
Intellia Therapeutics Reports Promising Three-Year Follow-Up Data for Lonvo-z in Hereditary Angioedema Patients

Intellia Therapeutics Reports Promising Three-Year Follow-Up Data for Lonvo-z in Hereditary Angioedema Patients

Lonvo-z showed a 98% reduction in HAE attacks for 10 patients over three-year follow-up, demonstrating promising safety and efficacy.Quiver AI SummaryIntellia Therapeutics has announced promising three-year follow-up data from its…

Continue ReadingIntellia Therapeutics Reports Promising Three-Year Follow-Up Data for Lonvo-z in Hereditary Angioedema Patients
Read more about the article Upstream Bio Presents Pharmacology Modeling Data Supporting Verekitug
Upstream Bio Presents Pharmacology Modeling Data Supporting Verekitug

Upstream Bio Presents Pharmacology Modeling Data Supporting Verekitug

Upstream Bio presents data suggesting verekitug offers greater potency than tezepelumab in targeting inflammatory diseases.Quiver AI SummaryUpstream Bio, Inc. presented data at the European Academy of Allergy & Clinical Immunology…

Continue ReadingUpstream Bio Presents Pharmacology Modeling Data Supporting Verekitug

End of content

No more pages to load